ClausRoehrbornMDProfessor and Chair

PubMed

• WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cmand 80-150-cmprostates.
  Mohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, Karim Daher, Neil Barber
  BJUI Compass. 2024-11-01
• 4 citations
  Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hype...
  Massimiliano Creta, Giorgio I Russo, Naeem Bhojani, Marcus J Drake, Christian Gratzke
  European Urology. 2024-10-01
• 1 citations
  Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study.
  Steve Kaplan, Ronald P Kaufman Jr, Thomas Mueller, Dean Elterman, Bilal Chughtai
  Prostate Cancer and Prostatic Diseases. 2024-09-01

Journal Articles

• Symptom Relief and Anejaculation After Aquablation or TURP: Subgroup Analysis from a Blinded Randomized Trial  
  Alexis E Te, Mark Plante, Barrett Cowan, Claus Roehrborn, Mohamed Bidair, Leo Doumanian, Andrew Arther, Gopal Badlani, Mark DeGuenther, Mark Sutton, BJU International
• Solitary recurrence of castration-resistant prostate cancer with low or undetectable levels of prostate specific antigen salvaged with local ablative radiation therapy...  
  Wang, C.J., Ying, J., Kapur, P., Wohlfeld, B., Roehrborn, C., and Nathan Kim, D.W., Oncology Letters, 1/1/2016
• Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment  
  Roehrborn, C.G., Egan, K.B., Miner, M.M., Ni, X., Wong, D.G., and Rosen, R.C., BJU International, 1/1/2016
• An Assessment of Patient Comfort and Morbidity after Robot-Assisted Radical Prostatectomy with Suprapubic Tube Versus Urethral Catheter Drainage  
  Morgan, M.S.C., Ozayar, A., Friedlander, J.I., Shakir, N., Antonelli, J.A., Bedir, S., Roehrborn, C.G., and Cadeddu, J.A., Journal of Endourology, 1/1/2016
• Light Reflectance Spectroscopy to Detect Positive Surgical Margins on Prostate Cancer Specimens  
  Morgan, M.S.C., Lay, A.H., Wang, X., Kapur, P., Ozayar, A., Sayah, M., Zeng, L., Liu, H., Roehrborn, C.G., and Cadeddu, J.A., Journal of Urology, 1/1/2016
• Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia  
  Gacci, M., Andersson, K.E., Chapple, C., Maggi, M., Mirone, V., Oelke, M., Porst, H., Roehrborn, C., Stief, C., and Giuliano, F., European Urology, 1/1/2016
• Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial  
  Simon, R.M., Howard, L.E., Moreira, D.M., Roehrborn, C., Vidal, A.C., Castro-Santamaria, R., and Freedland, S.J., European Urology, 1/1/2015
• 35 cm artificial urinary sphincter cuff erosion occurs predominantly in irradiated patients  
  Simhan, J., Morey, A.F., Singla, N., Tausch, T.J., Scott, J.F., Lemack, G.E., and Roehrborn, C.G., Journal of Urology, 1/1/2015
• Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy  
  Roehrborn, C.G., Spann, M.E., Myers, S.L., Serviss, C.R., Hu, L., and Jin, Y., Prostate Cancer and Prostatic Diseases, 1/1/2015
• Three year results of the prostatic urethral LIFT study  
  Roehrborn, C.G., Rukstalis, D.B., Barkin, J., Gange, S.N., Shore, N.D., Giddens, J.L., Bolton, D.M., Cowan, B.E., Cantwell, A.L., McVary, K.T., et al, Canadian Journal of Urology, 1/1/2015
• Efficacy and safety of a fixed-dose combination of dutasteride and tamsulosin treatment (Duodart) compared with watchful waiting with initiation of tamsulosin therapy ...  
  Roehrborn, C.G., Oyarzabal Perez, I., Roos, E.P.M., Calomfirescu, N., Brotherton, B., Wang, F., Palacios, J.M., Vasylyev, A., and Manyak, M.J., BJU International, 1/1/2015
• Feasibility of an Alternative Option for the Management of Male Lower Urinary Tract Symptoms  
  Roehrborn, C.G., Lowe, F.C., Gittelman, M., Wruck, J.M., and Verbeek, A.E., Journal of Urology, 1/1/2015
• Durability of the Prostatic Urethral Lift: 2-Year Results of the LIFT Study  
  Roehrborn, C.G., Gange, S.N., Shore, N.D., Giddens, J.L., Bolton, D.M., Cowan, B.E., Cantwell, A.L., McVary, K.T., Te, A.E., Gholami, S.S., et al, Urology Practice, 1/1/2015
• Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic h...  
  Roehrborn, C.G., Casabe, A., Glina, S., Sorsaburu, S., Henneges, C., and Viktrup, L, International Journal of Urology, 1/1/2015
• Single- versus dual-console robot-assisted radical prostatectomy: impact on intraoperative and postoperative outcomes in a teaching institution  
  Morgan, M.S.C., Shakir, N.A., Garcia-Gil, M., Ozayar, A., Gahan, J.C., Friedlander, J.I., Roehrborn, C.G., and Cadeddu, J.A., World Journal of Urology, 1/1/2015
• Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model  
  Lucca, I., Shariat, S.F., Briganti, A., Lotan, Y., Roehrborn, C.G., Montorsi, F., Remzi, M., Seitz, C., Fajkovic, H., Klingler, C., et al, Urologic Oncology: Seminars and Original Investigations, 1/1/2015
• Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs repeat biopsy for detection of prostate cancer in men with prior negative findi...  
  Lotan, Y., Haddad, A.Q., Costa, D.N., Pedrosa, I., Rofsky, N.M., and Roehrborn, C.G., Urologic Oncology: Seminars and Original Investigations, 1/1/2015
• Sexual Function in Men with Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia: Results of a 6-Month, Randomized, Double-...  
  Glina, S., Roehrborn, C.G., Esen, A., Plekhanov, A., Sorsaburu, S., Henneges, C., Büttner, H., and Viktrup, L, Journal of Sexual Medicine, 1/1/2015
• Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?  
  Egan, K.B., Miner, M.M., Suh, M., McVary, K., Ni, X., Roehrborn, C.G., Wittert, G., Wong, D.G., and Rosen, R.C., Andrology, 1/1/2015
• Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study  
  Costa, D.N., Yuan, Q., Xi, Y., Rofsky, N.M., Lenkinski, R.E., Lotan, Y., Roehrborn, C.G., Francis, F., Travalini, D., and Pedrosa, I., Urologic Oncology: Seminars and Original Investigations, 1/1/2015
• MR imaging–transrectal US fusion for targeted prostate biopsies: Implications for diagnosis and clinical management  
  Costa, D.N., Pedrosa, I., Donato, F., Roehrborn, C.G., and Rofsky, N.M., Radiographics, 1/1/2015
• Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate C...  
  Costa, D.N., Lotan, Y., Rofsky, N.M., Roehrborn, C., Liu, A., Hornberger, B., Xi, Y., Francis, F., and Pedrosa, I, Journal of Urology, 1/1/2015
• Histologic upgrading in patients eligible for active surveillance on saturation biopsy  
  Chung, P.H., Darwish, O.M., Roehrborn, C.G., Kapur, P., and Lotan, Y, Canadian Journal of Urology, 1/1/2015
• Durability of the prostatic urethral lift: 2-year results of the LIFT study  
  Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, I..., Urol Pract, 1/1/2015
• Prostate cancer detection using combined autofluorescence and light reflectance spectroscopy: Ex vivo study of human prostates  
  Sharma V, Olweny EO, Kapur P, Cadeddu JA, Roehrborn CG, Liu H, Biomed Opt Express, 1/1/2014
• Join now to see all

Books/Book Chapters

• Urology Practice 
  Chapter: Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. study 
  Page 26 - 32Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Rashid P, Moseley WG, Chin PT, Dowling WT, Freedman SJ, I...2015
• Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia 
  Chapter: Combination medical therapy for male lower urinary tract symptoms 
  Page 129 - 153C. G. Roehrborn2014
• Pocket Pharma: Dutasterida 
  Claus G. RoehrbornEditors: del proyecto: Hannah Cottle.Current Medicine Group, LTD2005
• Fast Facts 
  Chapter: Benign Prostatic Hyperplasia (BPH) 
  Claus G. Roehrborn2003
• PocketMedicine 
  Chapter: Benign prostatic hyperplasia (BPH) 
  Claus G. Roehrborn2001
• Fast Facts – Prostate specific antigen 
  Chapter: Benign Prostatic Hyperplasia (BPH) 
  Page 15 - 25Claus G. RoehrbornEditors: Julian Shah.Health Press Limited, Oxford, UKEdition 3rd,2001
• Benigne Prostatahyperplasie 
  Chapter: BPH Treatment Guidelines 
  Page 534 - 552Claus G. Roehrborn and John D. McConnellEditors: Hofner, Stief, Jonas.Springer-Verlag, Germany2000
• Clinical Evidence 
  Chapter: Benign prostatic hyperplasia 
  Page 453 - 461Michael J. Barry and Claus RoehrbornEditors: BMJ Publishing Group, BMA House, Tavistock Square.London, UKEdition 4th,2000
• Atlas of Clinical Urology 
  Chapter: Minimally Invasive Therapies for Benign Prostatic Hyperplasia 
  Claus G. RoehrbornEditors: E. Darracott Vaughan, Jr., and Aaron P. Perlmutter, series editors, John McConnell.1999
• Office Urology 
  Chapter: Medical management of benign prostatic obstruction 
  Michael J. Barry and Claus Roehrborn1999
• Clinical Evidence, Update in the Year 2000 
  Chapter: Benign prostatic hyperplasia 
  Page 303 - 310Michael J. Barry and Claus Roehrborn1999
• Year Book of Urology 1999 
  Chapter: Benign prostatic diseases 
  Page 117 - 168Claus G. RoehrbornEditors: Gerald L. Andriole, Jr. and Douglas E. Coplen.1999
• Prostate Cancer 
  Chapter: Response Criteria 
  Page 481 - 496H. Scher, A. Akdas, P. Ekman, E. P. Frenkel, Y. Homma, K. H. Kurth, C. G. Roehrborn, P. Smith and P. WhelanEditors: G. Murphy, S. Khoury, A. Partin and L. Denis.Publication Ltd1999
• Fast Facts – Prostate specific antigen 
  Chapter: Prostate volume and serum prostate-specific antigen (PSA) in benign prostatic hyperplasia (BPH) 
  Claus G. RoehrbornEditors: Michael Brawer and Roger Kirby.Health Press LimitedEdition 2nd,1999
• Textbook of Prostatic Diseases 
  Chapter: The role of guidelines in the diagnosis and treatment of benign prostatic hyperplasia (BPH) 
  Claus G. RoehrbornEditors: Herbert Lepor.W. B. Saunders, Philadelphia, PA1998
• Benign Prostatic Hyperplasia 
  Chapter: Response criteria in the treatment of benign prostatic hyperplasia 
  Page 17 - 25Claus G. RoehrbornEditors: FMJ Debruyne, A. Jardin, C. G. Roehrborn, S. Z. Langer.Adis International1998
• Benign Prostatic Hyperplasia 
  Chapter: Management of benign prostatic hyperplasia 
  Page 27 - 44Roger Kirby, Claus G. Roehrborn and Frans M. J. DebruyneEditors: FMJ Debruyne, A. Jardin, C. G. Roehrborn, S. Z. Langer.1998
• Surgery of the Prostate 
  Chapter: Complications of surgery 
  Page 345 - 366Claus G. RoehrbornEditors: Martin I. Resnick and Ian M. Thompson, Jr.Churchill Livingstone, Inc.1998
• Surgery of the Prostate 
  Chapter: Benign prostatic hyperplasia – complications 
  Claus G. RoehrbornEditors: Resnick and Thompson.1997
• Textbook of Benign Prostatic Hyperplasia 
  Roger Kirby, John McConnell, John Fitzpatrick, Claus Roehrborn, Peter BoyleIsis Medical Ltd, Oxford, UK1996
• Textbook of Benign Prostatic Hyperplasia 
  Chapter: The placebo effect in the treatment of benign prostatic hyperplasia 
  Page 239 - 258Claus G. RoehrbornEditors: Roger Kirby, John McConnell, John Fitzpatrick, Claus Roehrborn, Peter Boyle.Isis Medical Ltd, Oxford, UK1996
• Textbook of Benign Prostatic Hyperplasia 
  Chapter: Standard surgical interventions: TUIP/TURP/OPSU 
  Page 341 - 378Claus G. RoehrbornEditors: Roger Kirby, John McConnell, John Fitzpatrick, Claus Roehrborn, Peter Boyle.Isis Medical Ltd, Oxford, UK1996
• Textbook of Benign Prostatic Hyperplasia 
  Chapter: Treatment outcomes and their interpretation in benign prostatic hyperplasia 
  Page 473 - 506Claus G. RoehrbornEditors: Roger Kirby, John McConnell, John Fitzpatrick, Claus Roehrborn, Peter Boyle.Isis Medical Ltd, Oxford, UK1996
• Benign Prostatic Hyperplasia 
  Chapter: AHCPR (US) Guidelines in BPH 
  Claus G. RoehrbornEditors: Perinchery Narayan.1996
• First International Consultation on Prostate Cancer Proceedings 
  Chapter: Response criteria, progression and endpoints in human prostate cancer trials 
  Page 387 - 397P. Ekman, L. Boccon-Gibod, L. Denis, S. Khoury, D. McLeod, G. P. Murphy, J. E. Oesterling and C. G. RoehrbornEditors: G. Murphy, L. Denis, C. Chatelain, K. Griffiths, S. Khoury, A. T. Cockett.S. C. I.1996
• Join now to see all

Abstracts/Posters

• Detection of positive margins and diagnosis of aggressive prostate cancer by light scattering measurements
  Claus Roehrborn, Jeffrey Cadeddu, Venkaiah C, Kavuri, Xinlong Wang, Hanli Lu, AAGUS, 1/24/2014
• Patients meeting active surveillance criteria on saturation biopsy are at high risk for histologic grade progression on prostatectomy
  Paul Chung, Oussama Darwish, Sandeep Mehta, Claus Roehrborn, Yair Lotan, AUA National Meeting, Orlando, FL, 1/21/2014
• A comparison of patient comfort and satisfaction after robotic prostatectomy with suprapubic tube versus urethral catheter drainage
  Monica Morgan, Selahattin Bedir, Claus Roehrborn, Jeffrey A. Cadeddu, Jodi Antonelli, AUA National Meeting, Orlando, FL, 1/21/2014
• The risk of prostate cancer on subsequent biopsies in men with high-grade PIN and/or ASAP in a prospective study with central pathology (THE REDUCE TRIAL)
  Laura-Maria Krabbe, Claus G. Roehrborn, AUA National Meeting, Orlando, FL, 1/21/2014
• Two year durability of the prostatic urethral LIFT: Multi-center prospective study
  Claus G. Roehrborn, Daniel B. Rukstalis, Jonathan L. Giddens, Steven N. Gange, Neal D. Shore, Damien M. Bolton, Barrett E. Cowan, B. Thomas Brown, Kevin T. McVary, Ale..., AUA National Meeting, Orlando, FL, 1/21/2014
• Single versus dual console robot assisted laparoscopic prostatectomy: Impact on intraoperative and postoperative outcomes
  Maurillo Garcia-Gil, Nabeel Shakir, Monica Morgan, Asim Ozayar, Jeffrey Gahan, Claus Roehrborn, Jeffrey Cadeddu, AUA National Meeting, Orlando, FL, 1/21/2014
• Men with erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia with prostatic enlargement who responded to tadalafil/fina...
  Sidney Glina, Claus G. Roehrborn, Adil Esen, Ketan Kapadia, Alexey Plekhanov, Carsten Henneges, Sebastian Sorsaburu, Hartwig Büttner, Lars Viktru, AUA National Meeting, Orlando, FL, 1/21/2014
• Combination therapy with finasteride and tadalafil once daily for 6 months: A randomized, placebo-controlled study in men with lower urinary tract symptoms secondary t...
  Adolfo Casabe, Claus Roehrborn, Luigi Da Pozza, Sebastian Zepeda, Ralp Henderson, Sebastian Sorsaburu, Carsten Henneges, David Wong, Lars Viktrup, South Central Section of the AUA, Inc., 92 nd Annual Meeeting, Chicago, IL, 1/21/2013
• Nocturia improvement in the combination of Avodart and Tamsulosin (CombAT study)
  Oelke M, Roehrborn C, Wilson TH, Palacios J-M, Castro R, 28 th Annual EAU Congress, Milan, Italy, 1/19/2013
• Combination therapy with finasteride and tadalafil once daily for 6 months: A randomized, placebo-controlled study in men with lower urinary tract symptoms secondary t...
  Casabe AR, Roehrborn C, Da Pozza LF, Zepeda S, Henderson R, Sorsaburu S, Henneges C, Wong D, Vikrup L., 28 th Annual EAU Congress, Milan, Italy, 1/19/2013
• The risk of prostate cancer on subsequent biopsies in men with hgpin and/or asap in a prospective study with central pathology
  Claus G. Roehrborn, Timothy Wilson, Ramiro Castro-Santamaria, Michael Manyak, Matthew Somerville, AAGUS Meeting, New Orleans, LA, 1/5/2013
• Effects of finasteride and tadalafil combination therapy on lower urinary tract symptoms and erectile function in men with prostatic enlargement: A randomized, placebo...
  Sidney Glina, Claus Roehrborn, Ketan Kapadia, Alexey Piekhanov, Adil Esen, Sebastian Sorsaburu, Carsten Henneges, Hartwig Buettner, Lars Viktrup, The Journal of Urology, 1/1/2013
• Perioperative characteristics, surgical and post-operative outcomes in the geriatric population undergoing robotic- assisted laparoscopic prostatectomy: is this popula...
  Daniel Ramirez, Aditya Bagrodia, Yair Lotan, Claus Roehrborn, Philippe Zimmern, AUA South Central Section Meeting, Colorado Springs, CO, 1/27/2012
• Transurethral resection of the prostate in neurogenic patients
  Casey Seideman, Benjamin Dillon, Dominic Lee, Claus Roehrborn, Philippe Zimmern, and Gary Lemack, Society of Urodynamics and Female Urology (SUFU), New Orleans, LA, 1/3/2012
• Tadalafil 5mg once daily improves lower urinary tract symptoms suggestive of benign prostatic hyperplasia in men without erectile dysfunctiom
  Roehrborn C, Broderick G, Brock G, Xu L, Viktrup L, EAU Meeting, Paris, France, 1/1/2012
• Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors (pde5-is) alone or in combination with alpha blockers for lower urinary tract sym...
  Gacci M, Corona G, Salvi M, Vignozzi L, McVary KT, Kaplan SA, Roehrborn CG, Semi S, Mirone V, Carini M, Maggi M, EAU Meeting, Paris, France, 1/1/2012
• Incidence of benign prostatic hyperplasia clinical progression over time in the combination of avodart and tamsulosin (CombAT) study
  Emberton M, Roehrborn CG, Tubaro A, Wilston T, Castro R, EAU Meeting, Paris, France, 1/1/2012
• Effect of baseline variables on acute urinary retention and surgery related to benign prostatic hyperplasia in men from the combination of avodart and tamsulosin (Comb...
  Madersbacher S, Roehrborn CG, Barkin J, Tubaro A, Wilson T, Castro R, EAU Meeting, Paris, France, 1/1/2012
• Phosphodiesterase type 5 inhibitor use in the combination of Avodart and Tamsulosin (CombAT) study
  Claus G. Roehrborn, Paul Siami, Timothy H. Wilson, Ramiro Castro, J Urology, 1/1/2012
• A systematic review and meta- analysis of the use of phosphodiesterase type 5 inhibitors (PDE5-Is) for lower urinary tract symptoms (LUTS) secondary to benign prost...
  Linda Vignozzi, Kevin T. McVary, Steven A. Kaplan, Claus G. Roehrborn, Sergio Serni, Vincenzo Mirone, Marco Carini, Mario Maggi, Mauro Gacci, Giovanni Corona, Matteo..., J Urology, 1/1/2012
• Is the tadalafil effect on lower urinary tract symptoms related to severity of erectile dysfunction and is its effect on erectile dysfunction related to severity of lo...
  Hartmut Porst, Claus Roehrborn, Roberta Secrest, Lei Xu, Anne Esler, Lars Viktrup, J Urology, 1/1/2012
• Cluster patterns in male and female urologic symptoms: how much change occurs in the pattern of symptoms over time?
  Carol L. Link, Claus G. Roehrborn, Raymond C. Rosen, J. Urol, 1/1/2011
• Training laser prostate surgery with an advanced simulation based curriculum: The Victor&[REG] Greenlight trainer
  Robert Sweet, Vamsi Konchada, Saurabh Jain, Nan Zhang, Xiangmin Zhou, Daniel Burke, Carson Wong, Culley Carson, Claus Roehrborn, Yunhe Shen, J. Urol, 1/1/2011
• Comparison of benign prostatic hyperplasia outcomes in the combination of avodart and tamsulosin (COMBAT) and reduction of dutasteride in cancer events (REDUCE) studies
  Claus G. Roehrborn, Francesco Montorsi, Otis W. Brawley, Timothy H. Wilson, Roger S. Rittmaster, Ramiro Castro, J. Urol, 1/1/2011
• Prostatic urethral lift further characterized: a multi-center experience
  Henry Woo, Peter Chin, Damien Bolton, Prem Rashid, Jeffrey Thavaseelan, Gregory Jack, Reginald Bruskewitz, Claus Roehrborn, J. Urol, 1/1/2011
• Join now to see all

Lectures

• A lot of Trials, a lot of data - important lessons from the CONDUCT, PCPT, COMBAT and REDUCE trials. What you need to know 
  Gold Coast, Australia - 1/19/2016
• PERSPECTIVES: Decisional Regret - the overlooked cost of decision making and the implications of too many choices (Adult) 10 minutes each, 10 minute discussion 
  Gold Coast, Australia - 1/19/2016
• How to read a journal article and decide if you should pay attention 
  Gold Coast, Australia - 1/19/2016
• DEBATE: If you arent doing Transperineal Biopsies, you aren't doing it right - Negative 
  Gold Coast, Australia - 1/19/2016
• Anatomy of a failed Trial - Lessons from the ones that didn’t work 
  Gold Coast, Australia - 1/19/2016
• Prospective, Randomized, Blinded Study of Prostatic Urethral Lift (PUL): Four Year Results 
  Gold Coast, Australia - 1/19/2016
• 5-ARI's and high grade Prostate cancer - clinical hypothesis and evidence 
  Gold Coast, Australia - 1/19/2016
• mpMRI - implications for diagnosis and clinical management 
  Gold Coast, Australia - 1/19/2016
• Combination medical therapy for LUTS – are there limits?” 
  1/31/2015
• Critical Assessment of minimally invasive surgical therapies for BPH 
  1/31/2015
• State-of-the-Art Lecture: Surgical Treatment of BPH 
  Scottsdale, AZ - 1/27/2015
• State-of-the-Art on PSA and Genomic Markers/Test on Prostate Diseases 
  Santiago, Chile - 1/20/2015
• MRI Fusion Prostate Biopsy 
  Santiago, Chile - 1/20/2015
• Evaluation of BPH/LUTS: What is Really Necessary? 
  Santiago, Chile - 1/20/2015
• Update on Medical Treatment of BPH 
  Santiago, Chile - 1/20/2015
• The Issue of Complications of Medical Treatment of BPH. How Real Are They? 
  Santiago, Chile - 1/20/2015
• Minimally Invasive Procedures in BPH – What’s New and Good 
  Santiago, Chile - 1/20/2015
• Toxins, Vapor, Robots and Lifts: Does the future of MLUTS Need All This? 
  Chicago, IL - 1/7/2015
• Treatments for Localized Prostate Cancer: Considerations of Efficacy, Safety, Superiority and Cost Effectiveness of Newer Vs Older Options 
  Chicago, IL - 1/7/2015
• Update on Medical Therapy for LUTS/BPH 
  1/1/2015
• Unresolved issues in LUTS/BPH: Nocturia and Postvpoid Residual Urine 
  1/1/2015
• Medical & Surgical Management of BPH 
  Kingston, Jamaica - 1/23/2014
• PSA Failure after Radical Prostatectomy 
  Kingston, Jamaica - 1/23/2014
• Plenary – Evidence based treatment for BPH 
  Sao Paulo, Brazil - 1/22/2014
• Plenary – Evaluating the risk/benefit in our BPH patients 
  Sao Paulo, Brazil - 1/22/2014
• Join now to see all

Other

• Combination Medical Therapy for Male Lower Urinary Tract Symptoms In: Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia 
  Roehrborn CG
  1/1/2014
• Auto-fluorescence lifetime spectroscopy for prostate cancer detection: An optical biopsy approach 
  Sharma V, Kapur P, Olweny E, Cadeddu J, Roehrborn CR, Liu H, www.scopus.com
  1/1/2012
• Laser surgery simulation platform: Toward full-procedure training and rehearsal for Benign Prostatic Hyperplasia (BPH) therapy 
  Shen Y, Konchada V, Zhang N, Jain S, Zhou X, Burke D, Wong C, Carson C, Roehrborn C, Sweet R
  www.scopus.com
  1/1/2011
• Quick improvement of urinary symptoms of benign prostatic hyperplasia with silodosin (rapaflo) 
  Marks L, Roehrborn C
  www.scopus.com
  1/1/2009
• Management of benign prostatic hyperplasia 
  Barry M, Roehrborn C
  www.scopus.com
  1/1/1997
• Untersuchungen zur Beeinflussung Der Calciumoxalat-Kristallisation durch Inhibitoren und Urinproben in einem Gelmodell (Inhibition of Calcium- Oxalate Crystallization ... 
  Claus G. Roehrborn
  1/1/1985
• Join now to see all